|
1
|
Perz JF, Armstrong GL, Farrington LA,
Hutin YJ and Bell BP: The contributions of hepatitis B virus and
hepatitis C virus infections to cirrhosis and primary liver cancer
worldwide. J Hepatol. 45:529–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clark T, Maximin S, Meier J, Pokharel S
and Bhargava P: Hepatocellular carcinoma: Review of epidemiology,
screening, imaging diagnosis, response assessment, and treatment.
Curr Probl Diagn Radiol. 44:479–486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsueh CT, Liu D and Wang H: Novel
biomarkers for diagnosis, prognosis, targeted therapy and clinical
trials. Biomark Res. 1:12013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu JB, Qi FZ, Xu G, Chen GF, Qin LX and
Zhang JH: Value of alpha-fetoprotein and clinical characteristics
in patients with liver neoplasm. Neoplasma. 61:218–224. 2014.
View Article : Google Scholar
|
|
6
|
Prieto De Paula JM, Mayor Toranzo E,
Gallardo Borge L and Franco Hidalgo S: Small-cell lung cancer and
elevated CA 19.9 tumor marker levels. Arch Bronconeumol.
48:385–386. 2012.In Spanish. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang HX, Liu DD, Jin BJ, Wang YW, Liu Q,
Duan RB, Zhao P and Ma MX: Changes of serum trace elements, AFP,
CEA, SF, T3, T4 and IGF-II in different periods of rat liver
cancer. Chin J Cancer Res. 23:301–305. 2011. View Article : Google Scholar
|
|
8
|
Zhang D, Yu M, Xu T and Xiong B:
Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of
colorectal liver metastasis in Chinese population.
Hepatogastroenterology. 60:1297–1301. 2013.PubMed/NCBI
|
|
9
|
Benowitz S: Liver cancer biomarkers
struggling to succeed. J Natl Cancer Inst. 99:590–591. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong Y, He D, Peng Z, Peng W, Shi W, Wang
J, Li B, Zhang C and Duan C: Circular RNAs in cancer: An emerging
key player. J Hematol Oncol. 10:22017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Yang J, Zhou P, Le Y, Zhou C, Wang
S, Xu D, Lin HK and Gong Z: Circular RNAs in cancer: Novel insights
into origins, properties, functions and implications. Am J Cancer
Res. 5:472–480. 2015.PubMed/NCBI
|
|
14
|
Wang Y, Mo Y, Gong Z, Yang X, Yang M,
Zhang S, Xiong F, Xiang B, Zhou M, Liao Q, et al: Circular RNAs in
human cancer. Mol Cancer. 16:252017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar :
|
|
16
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Granados-Riveron JT and Aquino-Jarquin G:
The complexity of the translation ability of circRNAs. Biochim
Biophys Acta. 1859:1245–1251. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Greene J, Baird AM, Brady L, Lim M, Gray
SG, McDermott R and Finn SP: Circular RNAs: Biogenesis, Function
and Role in Human Diseases. Front Mol Biosci. 4:382017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren S, Xin Z, Xu Y, Xu J and Wang G:
Construction and analysis of circular RNA molecular regulatory
networks In liver cancer. Cell Cycle. 16:2204–2211. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bai F, Yano Y, Fukumoto T, Takebe A,
Tanaka M, Kuramitsu K, Anggorowati N, Rinonce HT, Widasari DI,
Saito M, et al: Quantification of pregenomic RNA and covalently
closed circular DNA in hepatitis B virus-related hepatocellular
carcinoma. Int J Hepatol. 2013:8492902013. View Article : Google Scholar
|
|
22
|
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z,
Yang J, Fan J, Liu L and Qin W: Hsa_circ_0001649: A circular RNA
and potential novel biomarker for hepatocellular carcinoma. Cancer
Biomark. 16:161–169. 2016. View Article : Google Scholar
|
|
23
|
Shang X, Li G, Liu H, Li T, Liu J, Zhao Q
and Wang C: Comprehensive circular RNA profiling reveals that
hsa_circ_0005075, a new circular RNA biomarker, is involved in
hepatocellular carcinoma development. Medicine (Baltimore).
95:e38112016. View Article : Google Scholar
|
|
24
|
Fu L, Yao T, Chen Q, Mo X, Hu Y and Guo J:
Screening differential circular RNA expression profiles reveals
hsa_circ_0004018 is associated with hepatocellular carcinoma.
Oncotarget. 8:58405–58416. 2017.PubMed/NCBI
|
|
25
|
Huang XY, Huang ZL, Xu YH, Zheng Q, Chen
Z, Song W, Zhou J, Tang ZY and Huang XY: Comprehensive circular RNA
profiling reveals the regulatory role of the
circRNA-100338/miR-141-3p pathway in hepatitis B-related
hepatocellular carcinoma. Sci Rep. 7:54282017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Greifenberg AK, Hönig D, Pilarova K,
Düster R, Bartholomeeusen K, Bösken CA, Anand K, Blazek D and Geyer
M: Structural and functional analysis of the Cdk13/Cyclin K
complex. Cell Rep. 14:320–331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Even Y, Escande ML, Fayet C and Genevière
AM: CDK13, a kinase involved in Pre-mRNA splicing, is a component
of the perinucleolar compartment. PLoS One. 11:e01491842016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim HE, Kim DG, Lee KJ, Son JG, Song MY,
Park YM, Kim JJ, Cho SW, Chi SG, Cheong HS, et al: Frequent
amplification of CENPF, GMNN and CDK13 genes in hepatocellular
carcinomas. PLoS One. 7:e432232012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Glažar P, Papavasileiou P and Rajewsky N:
circBase: A database for circular RNAs. RNA. 20:1666–1670. 2014.
View Article : Google Scholar
|
|
30
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rybak-Wolf A, Stottmeister C, Glažar P,
Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss
R, et al: Circular RNAs in the mammalian brain are highly abundant,
conserved, and dynamically expressed. Mol Cell. 58:870–885. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salzman J, Chen RE, Olsen MN, Wang PL and
Brown PO: Cell-type specific features of circular RNA expression.
PLoS Genet. 9:e10037772013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thomas M: Molecular targeted therapy for
hepatocellular carcinoma. J Gastroenterol. 44(Suppl 19): 136–141.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang H, Li RP, Liang P, Zhou YL and Wang
GW: miR-125a inhibits the migration and invasion of liver cancer
cells via suppression of the PI3K/AKT/mTOR signaling pathway. Oncol
Lett. 10:681–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wilson GS, Tian A, Hebbard L, Duan W,
George J, Li X and Qiao L: Tumoricidal effects of the JAK inhibitor
Ruxolitinib (INC424) on hepatocellular carcinoma in vitro. Cancer
Lett. 341:224–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun ZJ, Chen G, Hu X, Zhang W, Liu Y, Zhu
LX, Zhou Q and Zhao YF: Activation of PI3K/Akt/IKK-α/NF-kappaB
signaling pathway is required for the apoptosis-evasion in human
salivary adenoid cystic carcinoma: Its inhibition by quercetin.
Apoptosis. 15:850–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Booz GW, Day JN and Baker KM: Interplay
between the cardiac renin angiotensin system and JAK-STAT
signaling: Role in cardiac hypertrophy, ischemia/reperfusion
dysfunction, and heart failure. J Mol Cell Cardiol. 34:1443–1453.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Levine DA, Bogomolniy F, Yee CJ, Lash A,
Barakat RR, Borgen PI and Boyd J: Frequent mutation of the PIK3CA
gene in ovarian and breast cancers. Clin Cancer Res. 11:2875–2878.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Or YY, Hui AB, Tam KY, Huang DP and Lo KW:
Characterization of chromosome 3q and 12q amplicons in
nasopharyngeal carcinoma cell lines. Int J Oncol. 26:49–56.
2005.
|
|
40
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,
2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces
tumor cell invasion in colorectal cancer cells. Neoplasia.
10:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA ITCH has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015.
|
|
42
|
Simile MM, Latte G, Demartis MI, Brozzetti
S, Calvisi DF, Porcu A, Feo CF, Seddaiu MA, Daino L, Berasain C, et
al: Post-translational deregulation of YAP1 is genetically
controlled in rat liver cancer and determines the fate and
stem-like behavior of the human disease. Oncotarget. 7:49194–49216.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
O'Shea JJ, Gadina M and Schreiber RD:
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway.
Cell. 109(Suppl 1): S121–S131. 2002. View Article : Google Scholar
|
|
44
|
Arumuggam N, Bhowmick NA and Rupasinghe
HP: A Review: Phytochemicals targeting JAK/STAT signaling and IDO
expression in cancer. Phytother Res. 29:805–817. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lin CW, Chang YL, Chang YC, Lin JC, Chen
CC, Pan SH, Wu CT, Chen HY, Yang SC, Hong TM, et al: MicroRNA-135b
promotes lung cancer metastasis by regulating multiple targets in
the Hippo pathway and LZTS1. Nat Commun. 4:18772013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
He Y and Liu X: The tumor-suppressor gene
LZTS1 suppresses hepatocellular carcinoma proliferation by
impairing PI3K/Akt pathway. Biomed Pharmacother. 76:141–146. 2015.
View Article : Google Scholar : PubMed/NCBI
|
